APA (7th ed.) Citation

Nelson, F. R., Zvirbulis, R. A., Zonca, B., Li, K. W., Turner, S. M., Pasierb, M., . . . Wu, W. (2015). The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses. Rheumatology international, 35(1), 43-52. https://doi.org/10.1007/s00296-014-3047-6

Chicago Style (17th ed.) Citation

Nelson, F. R., R. A. Zvirbulis, B. Zonca, K. W. Li, S. M. Turner, M. Pasierb, P. Wilton, D. Martinez-Puig, and W. Wu. "The Effects of an Oral Preparation Containing Hyaluronic Acid (Oralvisc®) on Obese Knee Osteoarthritis Patients Determined by Pain, Function, Bradykinin, Leptin, Inflammatory Cytokines, and Heavy Water Analyses." Rheumatology International 35, no. 1 (2015): 43-52. https://doi.org/10.1007/s00296-014-3047-6.

MLA (9th ed.) Citation

Nelson, F. R., et al. "The Effects of an Oral Preparation Containing Hyaluronic Acid (Oralvisc®) on Obese Knee Osteoarthritis Patients Determined by Pain, Function, Bradykinin, Leptin, Inflammatory Cytokines, and Heavy Water Analyses." Rheumatology International, vol. 35, no. 1, 2015, pp. 43-52, https://doi.org/10.1007/s00296-014-3047-6.